BioMarin Pharmaceutical | 流动负债



Current Liabilities 更改 日
Acadia Pharmaceuticals USD 302.53M 92.34M 2025-03
Agios Pharmaceuticals USD 52.37M 28.79M 2025-03
Alnylam Pharmaceuticals USD 1.3B 225.22M 2025-06
Amgen USD 23.01B 91M 2025-03
Bayer EUR 27.96B 993M 2025-03
Biogen USD 3.18B 2.11B 2025-06
BioMarin Pharmaceutical USD 628.21M 21.22M 2025-03
Gilead Sciences USD 12B 279M 2024-12
Incyte USD 1.28B 608.18M 2025-06
Insmed USD 239.23M 58.29M 2025-03
Ionis Pharmaceuticals USD 250.29M 59.02M 2025-03
Moderna USD 1.6B 602M 2025-03
Neurocrine Biosciences USD 522.9M 15.2M 2025-03
PTC Therapeutics USD 595.39M 14.41M 2025-03
Regeneron Pharmaceuticals USD 3.57B 2.13B 2025-03
Roche Holding CHF 27.02B 424M 2024-12
Sanofi 29.16B 865M 2024-12
Sarepta Therapeutics USD 605.59M 126.1M 2025-03
Ultragenyx Pharmaceutical USD 344.15M 59.14M 2024-12
United Therapeutics USD 527.1M 194.4M 2025-06
Vertex Pharmaceuticals USD 3.56B 408.5M 2024-12


BioMarin Pharmaceutical 流动负债 - 当前值，历史数据，预测，统计，图表和经济日历 - Aug 2025.